Puri RK - Search Results

1

Medical applications of microarray technologies: a regulatory science perspective.

Petricoin EF 3rd, Hackett JL, Lesko LJ, Puri RK, Gutman SI, Chumakov K, Woodcock J, Feigal DW Jr, Zoon KC, Sistare FD. Petricoin EF 3rd, et al. Among authors: puri rk. Nat Genet. 2002 Dec;32 Suppl:474-9. doi: 10.1038/ng1029. Nat Genet. 2002. PMID: 12454641 Review.

2

Clinical Development of Gene Therapies: The First Three Decades and Counting.

Lapteva L, Purohit-Sheth T, Serabian M, Puri RK. Lapteva L, et al. Among authors: puri rk. Mol Ther Methods Clin Dev. 2020 Oct 10;19:387-397. doi: 10.1016/j.omtm.2020.10.004. eCollection 2020 Dec 11. Mol Ther Methods Clin Dev. 2020. PMID: 33209964 Free PMC article. Review.

3

Identification and characterisation of novel CAR-T cells to target IL13Rα2 positive human glioma in vitro and in vivo.

Leland P, Degheidy H, Lea A, Bauer SR, Puri RK, Joshi BH. Leland P, et al. Among authors: puri rk. Clin Transl Med. 2024 May;14(5):e1664. doi: 10.1002/ctm2.1664. Clin Transl Med. 2024. PMID: 38685487 Free PMC article.

4

Correction: Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with ⁸⁹Zirconium oxine for PET imaging.

Leland P, Kumar D, Nimmagadda S, Bauer SR, Puri RK, Joshi BH. Leland P, et al. Among authors: puri rk. J Transl Med. 2023 Sep 19;21(1):636. doi: 10.1186/s12967-023-04496-7. J Transl Med. 2023. PMID: 37726828 Free PMC article. No abstract available.

5

Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with ⁸⁹Zirconium oxine for PET imaging.

Leland P, Kumar D, Nimmagadda S, Bauer SR, Puri RK, Joshi BH. Leland P, et al. Among authors: puri rk. J Transl Med. 2023 Jun 7;21(1):367. doi: 10.1186/s12967-023-04142-2. J Transl Med. 2023. PMID: 37286997 Free PMC article.

6

A Novel Recombinant Modified Vaccinia Ankara Virus expressing Interleukin-13 Receptor α2 Antigen for Potential Cancer Immunotherapy.

Sato Y, Vatsan R, Joshi BH, Husain SR, Puri RK. Sato Y, et al. Among authors: puri rk. Curr Mol Med. 2023 Mar 31. doi: 10.2174/1566524023666230331085007. Online ahead of print. Curr Mol Med. 2023. PMID: 36999709

7

Characterization of Chimeric Antigen Receptor Modified T Cells Expressing scFv-IL-13Rα2 after Radiolabeling with 89Zirconium Oxine for PET Imaging.

Leland P, Kumar D, Nimaggada S, Bauer SR, Puri RK, Joshi BH. Leland P, et al. Among authors: puri rk. Res Sq [Preprint]. 2023 Jan 13:rs.3.rs-2242559. doi: 10.21203/rs.3.rs-2242559/v1. Res Sq. 2023. PMID: 36711796 Free PMC article. Updated. Preprint.

8

Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy.

Knudson KM, Hwang S, McCann MS, Joshi BH, Husain SR, Puri RK. Knudson KM, et al. Among authors: puri rk. Front Immunol. 2022 Apr 8;13:878365. doi: 10.3389/fimmu.2022.878365. eCollection 2022. Front Immunol. 2022. PMID: 35464460 Free PMC article. Review.

9

IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer.

Fujisawa T, Joshi BH, Takahashi S, Takasaki Y, Suzuki A, Ito K, Ochiai K, Tomishima K, Ishii S, Puri RK, Isayama H. Fujisawa T, et al. Among authors: puri rk. Diagnostics (Basel). 2021 Jun 23;11(7):1140. doi: 10.3390/diagnostics11071140. Diagnostics (Basel). 2021. PMID: 34201539 Free PMC article. Review.

10

IL-13Rα2 gene expression is a biomarker of adverse outcome in patients with adrenocortical carcinoma.

Kumar A, Bellayr IH, Singh HS, Puri RK. Kumar A, et al. Among authors: puri rk. PLoS One. 2021 Feb 16;16(2):e0246632. doi: 10.1371/journal.pone.0246632. eCollection 2021. PLoS One. 2021. PMID: 33591997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

419 results

Search Page